Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/prostate-specific-antigen-screening-impacts-on-biochemical-recurrence-EzT0EsmIUf
References (36)
-
F. Schröder, Monique J, Melissa Center, A. Jemal, J. Lortet-Tieulent, Elizabeth Ward, J. Ferlay, O. Brawley, F. Bray
Platinum Priority – Review – Prostate Cancer International Variation in Prostate Cancer Incidence and Mortality Rates -
R. Godtman, E. Holmberg, H. Lilja, J. Stranne, J. Hugosson (2015)
Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.European urology, 68 3
-
Y. Kitagawa, M. Namiki (2014)
Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in AsiaAsian Journal of Andrology, 17
-
The Japanese Urological Association. The Japanese Society of Pathology, Japan Radiological Society General Rule for Clinical and Pathological Studies on Prostate Cancer -
Center (2012)
International variation in prostate cancer incidence and mortality ratesEur. Urol., 61
-
H. Chandler (1985)
Data BaseJournal of Learning Disabilities, 18
-
J. Cullen, S. Elsamanoudi, S. Brassell, Yongmei Chen, Monica Colombo, Amita Srivastava, D. Mcleod (2012)
The burden of prostate cancer in Asian nationsJournal of Carcinogenesis, 11
-
David Miller, K. Hafez, A. Stewart, J. Montie, John Wei (2003)
Prostate carcinoma presentation, diagnosis, and stagingCancer, 98
-
T. Koie, C. Ohyama, S. Hatakeyama, A. Imai, T. Yoneyama, Y. Hashimoto, T. Yoneyama, Y. Tobisawa, Shogo Hosogoe, H. Yamamoto, Masatoh Kitayama, K. Hirota (2016)
Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomyInternational Journal of Clinical Oncology, 21
-
A. Stephenson, M. Kattan, J. Eastham, Z. Dotan, F. Bianco, H. Lilja, P. Scardino (2006)
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 24
-
A. D'Amico, R. Whittington, S. Malkowicz, D. Schultz, J. Tomaszewski, A. Wein (1997)
Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 4
-
M. Cooperberg, J. Hilton, P. Carroll (2011)
The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy. -
A. Jemal, S. Fedewa, Jiemin Ma, R. Siegel, C. Lin, O. Brawley, E. Ward (2015)
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.JAMA, 314 19
-
F. Schröder, J. Hugosson, M. Roobol, T. Tammela, M. Zappa, V. Nelen, M. Kwiatkowski, M. Luján, L. Määttänen, H. Lilja, L. Denis, F. Recker, Á. Páez, C. Bangma, S. Carlsson, D. Puliti, A. Villers, X. Rébillard, M. Hakama, U. Stenman, P. Kujala, K. Taari, G. Aus, A. Huber, T. Kwast, R. Schaik, H. Koning, S. Moss, Anssi Auvinen (2014)
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-upThe Lancet, 384
-
Kazuto Ito, S. Naito, Y. Kakehi, A. Okuyama, T. Imamura, H. Yasunaga, H. Akaza, S. Hinotsu, Y. Arai, T. Dokiya, S. Egawa, Kazuhiro Suzuki, H. Koga, N. Masumori, K. Akakura, K. Kawashima, K. Okihara (2010)
Updated Japanese Urological Association Guidelines on prostate‐specific antigen‐based screening for prostate cancer in 2010International Journal of Urology, 17
-
H. Grönberg (2003)
Prostate cancer epidemiologyThe Lancet, 361
-
K. Beckmann, M. O’Callaghan, R. Ruseckaite, N. Kinnear, C. Miller, S. Evans, David Roder, K. Moretti (2017)
Prostate cancer outcomes for men who present with symptoms at diagnosisBJU International, 119
-
V. Lorusso (2002)
Prostate CarcinomaTumori Journal, 88
-
Hiroyuki Takahashi, J. Epstein, S. Wakui, Toshihiro Yamamoto, B. Furusato, Miao Zhang (2014)
Differences in prostate cancer grade, stage, and location in radical prostatectomy specimens from United States and JapanThe Prostate, 74
-
DC Miller, KS Hafez, A Stewart, JE Montie, JT Wei (2003)
Prostate carcinoma presentation, diagnosis, and staging: an update form the National Cancer Data Base, 98
-
Jim Hu, P. Nguyen, Jialin Mao, J. Halpern, Jonathan Shoag, J. Wright, A. Sedrakyan (2017)
Increase in Prostate Cancer Distant Metastases at Diagnosis in the United StatesJAMA Oncology, 3
-
S. Sriprasad, P. Thompson (2001)
Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidenceBJU International, 87
-
A. Pelzer, D. Colleselli, J. Bektic, G. Schaefer, S. Ongarello, C. Schwentner, L. Pallwein, M. Mitterberger, E. Steiner, G. Bartsch, W. Horninger (2008)
Clinical and pathological features of screen vs non‐screen‐detected prostate cancers: is there a difference?BJU International, 102
-
H. Okubo, M. Ohori, Y. Ohno, J. Nakashima, R. Inoue, T. Nagao, M. Tachibana (2014)
Prediction of non‐biochemical recurrence rate after radical prostatectomy in a Japanese cohort: Development of a postoperative nomogramInternational Journal of Urology, 21
-
A. Marx, A. Hafner-Marx (2004)
World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs -
By Spencer, Kalli Spenc (2006)
Screening for Prostate Cancer -
Jonathan Shoag, S. Mittal, Jim Hu (2016)
Reevaluating PSA Testing Rates in the PLCO Trial.The New England journal of medicine, 374 18
-
S. Carlsson, M. Assel, D. Ulmert, A. Gerdtsson, J. Hugosson, A. Vickers, H. Lilja (2017)
Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.European urology, 71 1
-
Anthony Ta, N. Papa, N. Lawrentschuk, J. Millar, R. Syme, G. Giles, D. Bolton (2015)
Increased prostate cancer specific mortality following radical prostatectomy in men presenting with voiding symptoms—A whole of population studyProstate International, 3
-
G. Novara, V. Ficarra, S. Mocellin, T. Ahlering, P. Carroll, M. Graefen, G. Guazzoni, M. Menon, V. Patel, S. Shariat, A. Tewari, H. Poppel, F. Zattoni, F. Montorsi, A. Mottrie, R. Rosen, T. Wilson (2012)
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy.European urology, 62 3
-
F. Schröder, J. Hugosson, M. Roobol, T. Tammela, S. Ciatto, V. Nelen, M. Kwiatkowski, M. Luján, H. Lilja, M. Zappa, L. Denis, F. Recker, Á. Páez, L. Määttänen, C. Bangma, G. Aus, S. Carlsson, A. Villers, X. Rébillard, T. Kwast, P. Kujala, B. Blijenberg, U. Stenman, A. Huber, K. Taari, M. Hakama, S. Moss, H. Koning, A. Auvinen (2012)
Prostate-cancer mortality at 11 years of follow-up.The New England journal of medicine, 366 11
-
(2010)
The Japanese Society of Pathology, Japan Radiological Society General Rule for Clinical and Pathological Studies on Prostate Cancer -
A. Weiner, R. Matulewicz, S. Eggener, E. Schaeffer (2016)
Increasing incidence of metastatic prostate cancer in the United States (2004–2013)Prostate Cancer and Prostatic Diseases, 19
-
A. Stephenson, P. Scardino, J. Eastham, F. Bianco, Z. Dotan, P. Fearn, M. Kattan (2006)
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.Journal of the National Cancer Institute, 98 10
-
M. Drazer, D. Huo, S. Eggener (2015)
National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 22
-
S. Naito, K. Kuroiwa, N. Kinukawa, K. Goto, H. Koga, O. Ogawa, M. Murai, T. Shiraishi (2008)
Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate CancerThe Journal of urology, 180 3
- Publisher
- Wiley
- Copyright
- Copyright © 2018 The Japanese Urological Association
- ISSN
- 0919-8172
- eISSN
- 1442-2042
- DOI
- 10.1111/iju.13563
- Publisher site
- See Article on Publisher Site
Abstract
Journal
International Journal of Urology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;